ASTERASYS
Financials
Valuation Metrics
ASTERASYS's Market Cap is ₩1870B. At end of 2025 it was ₩4655B. Ranked #832 of 2,405 in KR market (top 35%), #377 of 1,627 on KOSDAQ (top 23%), #25 of 94 in Health Care Equipment & Services (top 27%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 187.01B KRW | KR#832/2,405 Sec#25/94 |
| Revenue | 39.61B KRW | KR#1,909/2,405 Sec#57/94 |
| Net Income | 6.09B KRW | KR#1,138/2,405 Sec#36/94 |
| Total Assets | 51.05B KRW | KR#2,190/2,405 Sec#73/94 |
| Net Assets | 45.22B KRW | KR#1,963/2,405 Sec#63/94 |
| Employees | 77 | KR#1,821/2,405 Sec#72/94 |
| Value | ||
| P/E | 30.73x | KR#1,332/2,405 Sec#43/94 |
| P/B | 4.14x | KR#2,213/2,405 Sec#84/94 |
| PEG | 0.43x | KR#684/2,405 Sec#27/94 |
| P/S | 4.72x | KR#2,141/2,405 Sec#75/94 |
| EV/EBITDA | 43.11x | KR#1,318/2,405 Sec#43/94 |
| FCF Yield | 1.89% | KR#1,071/2,405 Sec#31/94 |
| Profitability | ||
| ROE | 13.46% | KR#398/2,405 Sec#15/94 |
| ROA | 11.92% | KR#192/2,405 Sec#11/94 |
| Op. Margin | 10.76% | KR#479/2,405 Sec#27/94 |
| Revenue Growth | 31.60% | KR#366/2,405 Sec#19/94 |
| Earnings Growth | 72.09% | KR#464/2,405 Sec#23/94 |
| Financial Health | ||
| Debt Ratio | 12.90% | KR#202/2,405 Sec#14/94 |
| Total Debt | 1.00B KRW | KR#1,946/2,405 Sec#73/94 |
| FCF | 3.54B KRW | KR#988/2,405 Sec#27/94 |
| Cash | 4.33B KRW | KR#2,053/2,405 Sec#76/94 |
| Current Ratio | 7.56x | KR#156/2,405 Sec#14/94 |
| Net Debt/EBITDA | -0.78x | KR#424/2,405 Sec#14/94 |
| Dividend | ||
| Div. Yield | 2.15% | KR#888/2,405 Sec#22/94 |
| Div. Growth | 228.13% | KR#42/2,405 Sec#3/94 |
| Performance | ||
| 1Y Return | -66.84% | KR#2,253/2,405 Sec#88/94 |
| 1M Return | -21.98% | KR#1,974/2,405 Sec#86/94 |
| From 52W High | -71.17% | KR#2,087/2,405 Sec#77/94 |
| 1Y MDD | -69.60% | KR#1,938/2,405 Sec#70/94 |
| Trading | ||
| Volume | 4,401 shares | KR#2,133/2,405 Sec#87/94 |
| Trading Value | 21.7M KRW | KR#2,070/2,405 Sec#81/94 |
| Foreign Own. | 1.10% | KR#1,987/2,405 Sec#74/94 |
| Per Share | ||
| EPS | 162 KRW | KR#1,335/2,405 Sec#41/94 |
| BPS | 1,202 KRW | KR#2,256/2,405 Sec#86/94 |
Company Info
The company, Asterasys, established in 2015 for medical device manufacturing, is a small and medium-sized venture listed on KOSDAQ in 2025. It manufactures and sells anti-aging skin beauty devices using high-intensity focused ultrasound and non-invasive high-frequency, with Liftera as its main product. By the end of 2023, three new products were developed through KOL collaboration, and Coolfase and Coolsoniq obtained MFDS product approval. The company targets the global market after securing US FDA certification in 2026. Asterasys was established in 2015 and is headquartered in Seongdong-gu, Seoul.